Clinical Trial Update: The Effects of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Blepharitis During a Four-Week Treatment Period (P08638) [Phase 2]

View source ↗

Summary

Phase 2 trial comparing 1% azithromycin ophthalmic solution to placebo in blepharitis over four weeks; results update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Blepharitis

Drugs mentioned

• Azithromycin ophthalmic solution 1% (azithromycin ophthalmic solution)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Blepharitis | Phase 2 | Status: COMPLETED